Efficacy and safety of tyrosine kinase inhibitors and low dose immunotherapy in metastatic renal cell carcinoma.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Institution: Tata Memorial Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814878
